Ubiquilin 4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Ubiquilin-4 (UBQLN4) is a member of the ubiquilin family of proteins that function as ubiquitin receptors in protein quality control pathways. It plays a critical role in targeting ubiquitinated proteins to the proteasome for degradation.
- Gene Symbol: UBQLN4
- Protein Name: Ubiquilin-4
- Molecular Weight: ~66 kDa
- Aliases: UBIN, PROTI, Chap1
UBQLN4 contains multiple functional domains:
- N-terminal ubiquitin-like (Ubl) domain - interacts with proteasome
- Central STI (S/T-rich) domains - protein-protein interactions
- C-terminal ubiquitin-associated (UBA) domain - binds ubiquitin chains
- Ubiquitin Receptor: Binds polyubiquitinated proteins for proteasomal degradation
- Autophagy Receptor: Participates in selective autophagy
- ERAD Component: Involved in endoplasmic reticulum-associated degradation
- Chaperone Activity: Helps prevent protein aggregation
- ALS-FTD: UBQLN4 mutations cause autosomal dominant ALS with frontotemporal dementia
- IBMPFD: Inclusion body myopathy with early-onset Paget disease and FTD
- Alzheimer's Disease: Altered expression and aggregation in AD brain
- Proteostasis modulators
- Autophagy enhancers
- Small molecules to restore protein quality control
- Gene therapy approaches
The study of Ubiquilin 4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [^4]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [^5]
Ubiquilin-4 (UBQLN4) plays a critical role in the ubiquitin-proteasome system (UPS):
- Acts as a shuttle factor delivering ubiquitinated substrates to the proteasome
- Contains an N-terminal ubiquitin-like (Ubl) domain that interacts with proteasomal subunits
- C-terminal ubiquitin-associated (UBA) domain recognizes polyubiquitin chains
- Facilitates degradation of misfolded, damaged, or regulatory proteins
UBQLN4 participates in cellular protein quality control:
- Targets aggregation-prone proteins for degradation
- Prevents toxic protein aggregate formation
- Helps clear oxidative stress-damaged proteins
- Supports neuronal survival under proteotoxic stress
- UBQLN4 colocalizes with amyloid plaques and neurofibrillary tangles
- Genetic variants associated with AD risk
- Implicated in tau degradation pathways
- May influence Aβ-induced neurotoxicity
- UBQLN4 mutations cause familial ALS
- Dysregulated proteostasis in motor neurons
- Interaction with SOD1 and TDP-43 pathology
- Therapeutic target for UPS enhancement
- UBQLN4 overexpression in multiple cancers
- Role in DNA damage response
- Prognostic biomarker for poor survival
- Target for anticancer therapy
| Target |
Approach |
Status |
| UBQLN4 expression |
Gene therapy |
Preclinical |
| Proteasome enhancement |
Small molecules |
Investigational |
| Protein aggregate clearance |
Immunotherapy |
Research |
- Understanding UBQLN4 substrate specificity
- Developing small molecule modulators
- Gene therapy approaches for UBQLN4 deficiency
- Biomarker development using UBQLN4 levels